The global softgel capsules market is anticipated to witness significant growth, with its value projected to increase from US$8.7 billion in 2025 to US$13.2 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period (2025-2032). This growth is largely driven by rising demand for both nutraceutical and pharmaceutical products, particularly due to increasing health awareness and technological advancements in capsule formulation and production. The market is also benefitting from the rising popularity of convenient and efficient dosage forms, as well as a growing demand for plant-based capsule materials in response to shifting dietary preferences and regulatory requirements.
As consumer preferences continue to evolve, there is a noticeable shift towards capsule technologies that can address poorly soluble drugs, and non-animal-based capsule materials are gaining traction. This, along with the significant role that nutraceuticals play in healthcare, forms the basis for the increasing market demand.
Key Industry Highlights
Leading Region: North America is expected to dominate the market, holding about 35% of the global market share by 2025. This is due to the region’s well-established pharmaceutical and nutraceutical sectors, coupled with a mature regulatory environment, which fosters continuous innovation in softgel capsule technologies.
Fastest-growing Regional Market: Asia Pacific is poised to be the fastest-growing regional market for softgel capsules, largely driven by an expanding middle class, improving healthcare infrastructure, and rising health awareness across countries like China, India, and Japan.
Dominant & Fastest-growing Sources: Porcine gelatin will remain the leading source for softgel capsules, accounting for approximately 55% of market share in 2025. However, pullulan-based capsules are expected to experience the fastest growth due to their environmental and ethical benefits.
Dominant & Fastest-growing Material Types: Gelatin-based capsules will continue to hold a dominant market share of about 80% in 2025, but non-animal-based capsules, driven by vegan and halal dietary trends, are anticipated to see the highest growth.
Dominant Application Type: Nutraceuticals are expected to account for about 60% of softgel capsule applications in 2025, driven by the global trend toward preventive healthcare and tailored nutrition solutions.
Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/14608
Market Factors – Growth, Barriers, and Opportunity Analysis
Driver: Increasing Adoption of Vegan Lifestyles and Religious Dietary Restrictions
Veganism is growing globally, with the vegan population expanding at a compound annual rate of 6-8%, especially in North America and Europe. This shift is creating a demand for plant-based softgel capsules that comply with both vegan lifestyles and religious dietary restrictions, such as Halal and Kosher. As consumers become more conscious about their dietary choices, softgel manufacturers are innovating with alternative materials like starch, cellulose, and pullulan to meet these ethical demands while ensuring regulatory compliance.Restraint: Supply Chain Disruptions and Raw Material Availability
The softgel capsules market is significantly dependent on animal-derived gelatin, which is primarily sourced from porcine and bovine origins. Outbreaks of livestock diseases, such as African Swine Fever, have led to disruptions in supply chains and fluctuations in raw material prices. Additionally, environmental and ethical concerns regarding animal-derived products have forced companies to explore alternatives. These supply chain challenges create cost instability, particularly in price-sensitive markets.Opportunity: Rise in Nutraceutical Demand in Emerging Economies
Asia Pacific, in particular, is witnessing substantial growth in nutraceutical consumption, driven by rising disposable incomes and a growing middle class in countries like India and China. This trend is bolstered by government health initiatives and increasing public awareness of preventive healthcare, presenting a lucrative opportunity for companies to expand their presence in these emerging markets.
Category-wise Analysis
Material Insights
Gelatin-based capsules, which are expected to dominate the market with an 80% share by 2025, remain the go-to material due to their proven efficacy, cost-effectiveness, and versatility. Gelatin’s excellent gel strength and flexibility make it ideal for pharmaceutical and nutraceutical applications. However, non-animal-based capsules, particularly pullulan-based alternatives, are growing rapidly. These capsules, derived from starch fermentation, offer benefits such as biodegradability and compatibility with clean-label products, which is fueling their demand, especially in North America and Europe.Source Insights
The porcine gelatin segment remains dominant in terms of revenue, comprising about 55% of the softgel market in 2025. This is due to the material’s superior functional properties, including gel strength and thermoreversibility, which facilitate efficient encapsulation. However, regional religious restrictions, particularly in the Middle East and parts of Asia, have created a growing demand for alternatives. Pullulan-based capsules are gaining popularity due to their oxygen-impermeability and biodegradable nature, making them especially suitable for sensitive nutraceuticals.Application Insights
Nutraceuticals will continue to lead softgel capsule applications, accounting for approximately 60% of the market share in 2025. As the demand for fat-soluble vitamins, omega-3 fatty acids, and herbal supplements grows, softgel capsules provide an ideal delivery form that enhances bioavailability. The pharmaceutical sector, although smaller, is poised for steady growth, as softgel capsules are increasingly used for poorly soluble drugs, biologics, and specialty formulations.
Regional Insights
North America
North America is set to maintain its leadership in the softgel capsules market, driven by its mature pharmaceutical infrastructure, high consumer health awareness, and a growing preference for convenient dosage forms. The regulatory environment, led by the FDA, ensures high standards for product safety and efficacy, which encourages innovation and technological advancements in softgel capsule production. The increasing geriatric population, with its demand for customized nutrition, and the shift towards preventive healthcare are key factors boosting the regional market.Asia Pacific
Asia Pacific is expected to be the fastest-growing region for softgel capsules, with a projected CAGR higher than the global average from 2025 to 2032. The growth is attributed to rapid urbanization, rising disposable incomes, and an increased focus on preventive healthcare. Countries like China and India are seeing an upsurge in nutraceutical consumption, particularly among the expanding middle class. Furthermore, improving healthcare systems and regulatory standards are making the region an attractive market for both local and global softgel manufacturers.Europe
Europe is anticipated to hold around 25% of the softgel capsules market share by 2025, with countries like Germany, the U.K., France, and Spain leading the charge. The European market is shaped by strong regulations and a demand for high-quality, sustainable products. The aging population, coupled with a growing inclination towards dietary supplements, is pushing the demand for nutraceuticals and softgel capsules. The emphasis on sustainability and transparency in sourcing, along with strict environmental standards, is also driving innovation in plant-based softgel alternatives.
Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/14608
Competitive Landscape
The global softgel capsules market is moderately concentrated, with major players holding around 60% of the market share. Companies such as Catalent Pharma Solutions, Aenova Group, and Suheung Co. Ltd. are industry leaders, leveraging their technological expertise, vast manufacturing capabilities, and strong supply chains to maintain dominance in the market. In addition to these established players, a growing number of regional and niche manufacturers are focusing on plant-based softgel technologies and innovations, increasing competition in the market.
Key Industry Developments
Robinson Pharma expanded its softgel production capacity in May 2025 by adding 10 new machines, solidifying its position as the largest U.S. softgel manufacturer with a capacity of 23 billion softgels annually. This expansion is aimed at enhancing efficiency and reinforcing its leadership in the custom nutraceutical manufacturing space.
Jupiter Neurosciences partnered with Catalent Pharma in March 2025 to manufacture JOTROL softgel capsules for a Phase 2a Parkinson’s trial. This collaboration aims to evaluate the safety, tolerability, and pharmacokinetics of JOTROL, which represents an innovative therapeutic approach in neurological conditions.
Icaritin (ICA), a natural extract from Epimedium, received approval as a Class 1.2 Traditional Chinese Medicine (TCM) innovative drug for advanced hepatocellular carcinoma in February 2025. The approval highlights the growing trend of using natural extracts in softgel formulations for chronic disease management.
Key Players in the Softgel Capsules Market
Catalent Pharma Solutions, Inc.
Aenova Group
Suheung Co., Ltd.
Lonza Group AG
Capsugel (a Lonza business)
Softgel Technologies Ltd.
Patheon (Thermo Fisher Scientific Inc.)
R. P. Scherer Corporation
Evonik Industries AG
Martinswerk GmbH
Oval International Ltd.
Pharmax Ltd.
Xcelience Ltd.
CPL Aromas
Nitta Gelatin Inc.
Future Outlook
The softgel capsules market is expected to continue growing at a robust pace, driven by rising demand for nutraceuticals, pharmaceutical innovations, and the growing trend of vegan and ethical consumption. The market will likely see increased diversification with innovations in plant-based materials, such as pullulan and cellulose-based capsules, alongside a stronger emphasis on sustainability. Regulatory pressure and ethical consumer preferences will further shape the market, creating significant opportunities for both established and emerging players. The industry’s focus on improving the bioavailability of drugs and expanding the range of encapsulated ingredients will ensure that softgel capsules remain a popular choice for delivering a wide range of healthcare and wellness products.
